Official websites use .gov
A
.gov
website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS
A
lock
(
) or
https://
means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
The National Institutes of Health wasted no time and putting pandemic stimulus money to use. It launched RADx, a program to enlist industry in academia in a biomedical engineering approach to the pandemic.
Read more and listen to the interview at the Federal News Network.
An injectable electrode could prove a better way to ease chronic nerve pain than opioid painkillers or bulky and expensive implants, animal research suggests.
The podcast Epidemic, hosted by Dr. Celine Grounder and Robert Klain, featured episode 21: Are Antibodies the Holy Grail? Guests for this podcast episode are NIBIB's Kaitlyn Sadtler and NIAID's Matthew Memoli, who discuss the SARS-CoV-2 serology study they are conducting at NIH.
Dr. Kaitlyn Sadtler of the National Institutes of Health still identifies with her younger self, running through the sprinklers and going to the Frederick County Fair. She earned a bachelor's degree in biological sciences and a Ph.D.and now is an investigator at the NIBIB at the NIH in Bethesda.
For more, visit WJLA-TV.
The National Institutes of Health is launching a new initiative to turbocharge innovation, development and commercialization of COVID-19 testing technologies as a way to help society get back to a place where restrictions can be lifted.
The National Institutes of Health on Wednesday announced a new $1.5 billion initiative to rapidly develop coronavirus diagnostics, an effort it says will result in the deployment of “millions of tests per week” by late summer or fall of this year.
The U.S. National Institutes of Health (NIH) today announced a $1.5 billion initiative to speed breakthroughs in diagnostic tests for the virus that causes COVID-19. The program aims to increase the U.S. capacity for SARS-CoV-2 testing up to 100-fold by late summer, in time for the start of the flu season.
A competition between researchers is part of a $1.5 billion program that seeks to speed development of accurate, quick and easy-to-use COVID-19 tests, NIH announced Wednesday.
In this interview, David Zierler, Oral Historian for AIP, interviews Richard Leapman, Senior Investigator in the National Institute for Biomedical Imaging and Bioengineering and Scientific Director of the intramural program. Leapman recounts his childhood in England and he describes his early and formative experience playing with an optical microscope. Source: American Institute of Physics
